Helius Medical Technologies Return on Equity

Helius Medical Technologies (HSDT) currently reports a ROE of 112.93%. That is above the Technology sector average of 34.31%. Use the charts on this page to explore Helius Medical Technologies's ROE history and peer comparisons.

Helius Medical Technologies's ROE of 112.93% is higher than the Technology sector average of 34.31%. That is roughly 229.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Helius Medical Technologies's current 112.93% should be judged against Technology norms (sector average: 34.31%) and against HSDT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 112.93%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 34.31%. From there, open related valuation or income-statement pages for Helius Medical Technologies, and consider following HSDT for alerts when major investors trade the stock.

Helius Medical Technologies is classified in the Technology sector. On ROE, it currently shows 112.93% versus a sector average near 34.31%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing HSDT with unrelated industries.